Bowles; Owen Joseph
Patent Applications and Registrations
Patent applications and USPTO patent grants for Bowles; Owen Joseph.The latest application filed is for "mek inhibitors and methods of their use".
- Bowles; Owen Joseph - Pacifica CA
- Bowles; Owen Joseph - Burlingame CA
| Patent | Date |
|---|---|
| MEK Inhibitors and Methods of Their Use App 20200283383 - Aay; Naing ; et al. | 2020-09-10 |
| Mek Inhibitors And Methods Of Their Use App 20200031770 - Aay; Naing ; et al. | 2020-01-30 |
| MEK Inhibitors and Methods of Their Use App 20190144382 - Aay; Naing ; et al. | 2019-05-16 |
| MEK Inhibitors And Methods Of Their Use App 20170166523 - Aay; Naing ; et al. | 2017-06-15 |
| MEK Inhibitors And Methods Of Their Use App 20150141399 - Aay; Naing ; et al. | 2015-05-21 |
| Azetidines as MEK Inhibitors for the Treatment of Proliferative Diseases App 20140275527 - Aay; Naing ; et al. | 2014-09-18 |
| Raf modulators and methods of use Grant 8,697,737 - Anand , et al. April 15, 2 | 2014-04-15 |
| Benzoxazepines as inhibitors of PI3K/mTOR and methods of their use and manufacture Grant 8,648,066 - Anand , et al. February 11, 2 | 2014-02-11 |
| Benzoxazepines as inhibitors of PI3K/mTOR and methods of their use and manufacture Grant 8,637,499 - Aay , et al. January 28, 2 | 2014-01-28 |
| Azetidines as MEK inhibitors for the treatment of proliferative diseases Grant 8,362,002 - Aay , et al. January 29, 2 | 2013-01-29 |
| Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture App 20120258953 - Aay; Naing ; et al. | 2012-10-11 |
| Kinase modulators and methods of use Grant 8,076,338 - Anand , et al. December 13, 2 | 2011-12-13 |
| Azetidines as MEK Inhibitors for the Treatment of Proliferative Diseases App 20110263558 - Aay; Naing ; et al. | 2011-10-27 |
| Tropane compounds Grant 8,012,956 - Rice , et al. September 6, 2 | 2011-09-06 |
| Azetidines as MEK inhibitors for the treatment of proliferative diseases Grant 7,915,250 - Aay , et al. March 29, 2 | 2011-03-29 |
| Raf Modulators And Methods Of Use App 20110071145 - Anand; Neel Kumar ; et al. | 2011-03-24 |
| Anaplastic lymphoma kinase modulators and methods of use Grant 7,872,014 - Anand , et al. January 18, 2 | 2011-01-18 |
| Raf modulators and methods of use Grant 7,846,959 - Anand , et al. December 7, 2 | 2010-12-07 |
| Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture App 20100298290 - Anand; Neel Kumar ; et al. | 2010-11-25 |
| Azetidines as MEK Inhibitors for the Treatment of Proliferative Diseases App 20100249096 - Aay; Naing ; et al. | 2010-09-30 |
| Azetidines as MEK inhibitors for the treatment of proliferative diseases Grant 7,803,839 - Aay , et al. September 28, 2 | 2010-09-28 |
| Tropane compounds App 20090163471 - Rice; Kenneth D. ; et al. | 2009-06-25 |
| Azetidines as MEK Inhibitors for the Treatment of Proliferative Diseases App 20090156576 - Aay; Naing ; et al. | 2009-06-18 |
| Kinase Modulators and Methods of Use App 20080076774 - Anand; Neel K. ; et al. | 2008-03-27 |
| Raf Modulators and Methods of Use App 20080009488 - Anand; Neel Kumar ; et al. | 2008-01-10 |
| Anaplastic lymphoma kinase modulators and methods of use App 20070032515 - Anand; Neel Kumar ; et al. | 2007-02-08 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 